See more : Boill Healthcare Holdings Limited (1246.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Fortive Corporation (FTV) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Fortive Corporation, a leading company in the Hardware, Equipment & Parts industry within the Technology sector.
- FY Financial (Shenzhen) Co., Ltd. (8452.HK) Income Statement Analysis – Financial Results
- KP Tissue Inc. (KPT.TO) Income Statement Analysis – Financial Results
- Blue Energy Limited (BUENF) Income Statement Analysis – Financial Results
- AURYN Mining Corporation (AUMC) Income Statement Analysis – Financial Results
- Mitsubishi Shokuhin Co., Ltd. (7451.T) Income Statement Analysis – Financial Results
Fortive Corporation (FTV)
About Fortive Corporation
Fortive Corporation designs, develops, manufactures, markets, and services professional and engineered products, software, and services worldwide. Its Intelligent Operating Solutions segment offers connected reliability tools; environment, health, safety, and quality enterprise software products; facility and asset lifecycle software; pre-construction planning and construction procurement solutions; ruggedized professional test tools; electric, pressure, and temperature calibration tools; and portable gas detection tools for a range of vertical end markets including manufacturing, process industries, healthcare, utilities and power, communications and electronics, and others. It markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL brands. The company's Precision Technologies segment provides electrical test and measurement instruments and services; energetic material devices; and sensor and control system solutions for power and energy, medical equipment, food and beverage, aerospace and defense, off-highway vehicles, electronics, semiconductors, and other general industrial markets. This segment markets its products under the ANDERSON-NEGELE, GEMS, SETRA, HENGSTLER-DYNAPAR, QUALITROL, PACIFIC SCIENTIFIC, KEITHLEY, and TEKTRONIX brands. Its Advanced Healthcare Solutions segment offers hardware and software products and services, including instrument and device reprocessing, instrument tracking, biomedical test tools, radiation safety monitoring, and asset management services; subscription-based surgical inventory management systems to facilitate inventory management and regulatory compliance, as well as technical, analytical, and compliance services to determine radiation exposure services under the ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, RAYSAFE, and STERRAD brands. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.07B | 5.83B | 5.25B | 4.63B | 7.32B | 6.45B | 6.66B | 6.22B | 6.18B | 6.34B | 5.96B | 5.79B |
| Cost of Revenue | 2.47B | 2.46B | 2.25B | 2.03B | 3.64B | 3.13B | 3.36B | 3.19B | 3.18B | 3.29B | 3.10B | 3.02B |
| Gross Profit | 3.59B | 3.36B | 3.01B | 2.61B | 3.68B | 3.32B | 3.30B | 3.03B | 3.00B | 3.05B | 2.86B | 2.76B |
| Gross Profit Ratio | 59.26% | 57.73% | 57.23% | 56.29% | 50.28% | 51.47% | 49.56% | 48.73% | 48.48% | 48.12% | 48.04% | 47.76% |
| Research & Development | 397.80M | 401.50M | 354.80M | 320.70M | 456.70M | 414.30M | 406.00M | 384.80M | 377.70M | 387.60M | 378.30M | 352.70M |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 2.06B | 1.96B | 1.84B | 1.75B | 2.22B | 1.73B | 1.54B | 1.40B | 1.35B | 1.42B | 1.34B | 1.28B |
| Other Expenses | 0.00 | -15.60M | -14.10M | -2.40M | -6.20M | -3.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 2.46B | 2.36B | 2.19B | 2.07B | 2.68B | 2.14B | 1.94B | 1.79B | 1.73B | 1.80B | 1.72B | 1.64B |
| Cost & Expenses | 4.93B | 4.82B | 4.44B | 4.10B | 6.32B | 5.27B | 5.30B | 4.98B | 4.91B | 5.09B | 4.82B | 4.66B |
| Interest Income | 0.00 | 98.30M | 103.20M | 148.50M | 142.60M | 0.00 | 0.00 | 2.60M | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 123.50M | 98.30M | 103.20M | 148.50M | 142.60M | 97.00M | 86.00M | 49.00M | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 456.80M | 465.60M | 395.50M | 384.00M | 341.50M | 260.80M | 158.30M | 176.40M | 176.90M | 178.00M | 159.70M | 145.00M |
| EBITDA | 1.57B | 1.47B | 1.21B | 947.80M | 936.10M | 1.44B | 1.30B | 1.42B | 1.45B | 1.39B | 1.30B | 1.27B |
| EBITDA Ratio | 25.90% | 24.98% | 23.34% | 19.87% | 18.98% | 22.26% | 22.97% | 22.85% | 23.41% | 21.92% | 21.85% | 22.00% |
| Operating Income | 1.13B | 987.40M | 812.80M | 539.40M | 1.00B | 1.18B | 1.35B | 1.25B | 1.27B | 1.25B | 1.14B | 1.13B |
| Operating Income Ratio | 18.69% | 16.95% | 15.47% | 11.64% | 13.72% | 18.26% | 20.36% | 20.02% | 20.55% | 19.65% | 19.18% | 19.49% |
| Total Other Income/Expenses | -142.90M | -113.90M | -135.30M | 968.30M | -107.20M | -100.00M | 141.20M | 135.30M | 0.00 | 33.90M | 0.00 | -42.60M |
| Income Before Tax | 990.80M | 873.50M | 677.50M | 1.51B | 874.50M | 1.08B | 1.28B | 1.20B | 1.27B | 1.28B | 1.14B | 1.13B |
| Income Before Tax Ratio | 16.34% | 14.99% | 12.89% | 32.53% | 11.95% | 16.71% | 19.29% | 19.23% | 20.55% | 20.19% | 19.18% | 19.49% |
| Income Tax Expense | 125.00M | 118.30M | 63.30M | 55.50M | 149.10M | 160.10M | 239.70M | 324.70M | 405.90M | 395.80M | 312.30M | 364.10M |
| Net Income | 865.80M | 755.20M | 608.40M | 1.61B | 738.90M | 2.91B | 1.04B | 872.30M | 863.80M | 883.40M | 830.90M | 763.70M |
| Net Income Ratio | 14.27% | 12.96% | 11.58% | 34.81% | 10.09% | 45.16% | 15.69% | 14.01% | 13.98% | 13.94% | 13.94% | 13.20% |
| EPS | 2.46 | 2.12 | 1.64 | 4.58 | 2.20 | 8.43 | 3.01 | 2.52 | 2.50 | 2.56 | 2.41 | 2.21 |
| EPS Diluted | 2.43 | 2.09 | 1.63 | 4.30 | 2.17 | 8.31 | 2.96 | 2.51 | 2.50 | 2.56 | 2.41 | 2.21 |
| Weighted Avg Shares Out | 352.50M | 356.40M | 349.00M | 337.40M | 335.80M | 345.50M | 347.50M | 345.70M | 345.20M | 345.20M | 345.20M | 345.20M |
| Weighted Avg Shares Out (Dil) | 355.60M | 360.80M | 352.30M | 359.00M | 340.00M | 350.70M | 352.60M | 347.30M | 345.20M | 345.20M | 345.20M | 345.20M |
Fortive (FTV) Q4 Earnings & Revenues Beat Estimates, Rise Y/Y
Fortive Corp (FTV) Q4 2023 Earnings Call Transcript
Fortive (FTV) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Fortive (FTV) Q4 Earnings and Revenues Beat Estimates
Fortive Reports Strong Fourth Quarter and Full Year 2023 Results; Introduces First Quarter and Full Year 2024 Outlook
Top 5 Tech Stocks Set to Beat on Earnings in the Next 7 Days
PTC Set to Report Q1 Earnings: Here's What You Should Know
Unveiling Fortive (FTV) Q4 Outlook: Wall Street Estimates for Key Metrics
Fortive (FTV) Reports Next Week: Wall Street Expects Earnings Growth
BillingPlatform Secures $90 Million Growth Equity Investment from FTV Capital
Source: https://incomestatements.info
Category: Stock Reports